Cardiome Reports First Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Cardiome Pharma (CRME) Misses Q1 EPS by 5c
May 15, 2017 4:01 PM EDTCardiome Pharma (NASDAQ: CRME) reported Q1 EPS of ($0.20), $0.05 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $5.2 million versus the consensus estimate of $6.92 million.
For earnings history and earnings-related data on Cardiome Pharma (CRME) click here.
... More